1
|
Furtado DZS, Leite FBVDM, Jedlicka LDL, Souza DS, Barreto CN, da Silva HDT, Assunção NA. Targeted analysis reveals alteration in pathway in 5p minus individuals. Biomed Chromatogr 2020; 34:e4673. [PMID: 31385327 DOI: 10.1002/bmc.4673] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2019] [Revised: 07/13/2019] [Accepted: 07/29/2019] [Indexed: 11/07/2022]
Abstract
Cri du Chat or 5p minus (5p-) syndrome is characterized by a deletion located on the chromosome 5 short (-p) arm and has an incidence rate of 1 in 50,000 individuals worldwide. This disease manifests in disturbances across a range of systems biochemicals. Therefore, a targeted metabolomics analysis was evaluated in patients with 5p- syndrome to help unravel the biochemical changes that occur in this disease. Urine samples were collected from people of both sexes aged 1-38 years old and analyzed by ultra-performance liquid chromatography coupled to mass spectrometry. Student' statistical test, metabolomic pathway analysis and metabolite set enrichment analysis were applied to the data. Alterations of some amino acids and amine biogenics levels were found in Cri du Chat Syndrome individuals. The alteration of most of these metabolites is associated with energy recuperation and glycolysis. In general, we found the catabolism of some metabolic pathways to be affected in 5p- patients.
Collapse
Affiliation(s)
- Danielle Zildeana Sousa Furtado
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil
| | - Fernando Brunale Vilela de Moura Leite
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil
| | - Leticia Dias Lima Jedlicka
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil.,Instituto de Estudos em Saúde e Biológicas, Saúde Coletiva, Universidade Federal do Sul e Sudeste do Pará, Brazil
| | - Danilo Santos Souza
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil.,Núcleo de Graduação em Agroindústria, Universidade Federal de Sergipe, Brazil
| | - Cleber Nunes Barreto
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil
| | - Heron Dominguez Torres da Silva
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil
| | - Nilson Antonio Assunção
- Laboratório de Radicais Livres em Sistemas Biológicos e Bioanalítica, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Brazil
| |
Collapse
|
2
|
Furtado DZS, de Moura Leite FBV, Barreto CN, Faria B, Jedlicka LDL, de Jesus Silva E, da Silva HDT, Bechara EJH, Assunção NA. Profiles of amino acids and biogenic amines in the plasma of Cri-du-Chat patients. J Pharm Biomed Anal 2017; 140:137-145. [DOI: 10.1016/j.jpba.2017.03.034] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 03/15/2017] [Accepted: 03/17/2017] [Indexed: 11/16/2022]
|
3
|
Lefranc V, de Luca A, Hankard R. Protein-energy malnutrition is frequent and precocious in children with cri du chat syndrome. Am J Med Genet A 2016; 170A:1358-62. [DOI: 10.1002/ajmg.a.37597] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 01/27/2016] [Indexed: 11/08/2022]
Affiliation(s)
- Violaine Lefranc
- Pédiatrie Multidisciplinaire-Nutrition de l'Enfant; CHU Poitiers; Poitiers France
| | - Arnaud de Luca
- Pédiatrie Multidisciplinaire-Nutrition de l'Enfant; CHU Poitiers; Poitiers France
- Inserm, CIC1402; Poitiers France
- University of Poitiers; Poitiers France
| | - Régis Hankard
- Inserm U 1069; Tours France
- University of Tours; Tours France
| |
Collapse
|
4
|
Cochran L, Moss J, Nelson L, Oliver C. Contrasting age related changes in autism spectrum disorder phenomenology in Cornelia de Lange, Fragile X, and Cri du Chat syndromes: Results from a 2.5 year follow-up. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 2015; 169:188-97. [PMID: 25989416 DOI: 10.1002/ajmg.c.31438] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Little is known about the way in which the characteristics of autism spectrum disorder (ASD) develop and manifest across the age span in individuals with genetic syndromes. In this study we present findings from a two and a half year follow-up of the characteristics associated with ASD in three syndromes: Cornelia de Lange (CdLS), Fragile X (FXS), and Cri du Chat (CdCS). Parents and carers of 251 individuals (CdLS=67, CdCS=42, and FXS=142) completed the Social Communication Questionnaire (SCQ) at Time 1 (T1) and again two and a half years later (T2). The FXS and CdLS groups were more likely to meet the cut-offs for both autism and ASD and show greater severity of ASD related behaviors, at both T1 and T2, compared to the CdCS group. Older individuals (>15yrs) with CdLS were more likely to meet the cut off for ASD than younger individuals (≤15 yrs) with the syndrome and more likely to show greater severity of social impairments. In FXS repetitive behaviors were found to become less prominent with age and in CdCS social impairments were reported to be more severe with age. There were no significant changes between T1 and T2 in the severity of ASD characteristics in the CdCS and CdLS groups. The FXS group showed significantly fewer repetitive behaviors and less severe impairments in social interaction over this time frame. The findings suggest that while there may be similarities in overall severity and presentation of ASD characteristics in CdLS and FXS, these characteristics have divergent patterns of development within these groups.
Collapse
|
5
|
Yáñez-Vico RM, Rodríguez-Caballero A, Iglesias-Linares A, Guerra-López N, Torres-Lagares D, Machuca-Portillo G, Solano-Reina E, Gutiérrez-Pérez JL. Craniofacial characteristics in cri-du-chat syndrome. ACTA ACUST UNITED AC 2011; 110:e38-44. [PMID: 21112524 DOI: 10.1016/j.tripleo.2010.08.021] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2010] [Revised: 07/21/2010] [Accepted: 08/20/2010] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The purpose of this study was to analyze craniofacial characteristics from lateral head profile radiographs of patients with cri-du-chat (CdC) syndrome. STUDY DESIGN The craniofacial morphology of 10 CdC patients was evaluated using standard cephalometric methods, measuring 39 craniofacial variables on cephalometric x-ray images. RESULTS The principal characteristics were skeletal class II malocclusion, caused by mandibular retrognathism, dental biprotrusion, and a small upper airway. Additionally, 70% of patients had a steep palatal plane angle; the cranial base angle was flattened, also in 70% of patients. CONCLUSIONS Results indicated that the deletion of 5p had an impact on the cranial base, maxilla, mandible, and upper airway, causing distinctive features to become apparent through irregular growth.
Collapse
Affiliation(s)
- Rosa-María Yáñez-Vico
- Master's Program in Orthodontics and Dentofacial Orthopedics, School of Dentistry, University of Seville, Seville, Spain
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Abstract
The Cri du Chat syndrome (CdCS) is a genetic disease resulting from a deletion of variable size occurring on the short arm of chromosome 5 (5p-). The incidence ranges from 1:15,000 to 1:50,000 live-born infants. The main clinical features are a high-pitched monochromatic cry, microcephaly, broad nasal bridge, epicanthal folds, micrognathia, abnormal dermatoglyphics, and severe psychomotor and mental retardation. Malformations, although not very frequent, may be present: cardiac, neurological and renal abnormalities, preauricular tags, syndactyly, hypospadias, and cryptorchidism. Molecular cytogenetic analysis has allowed a cytogenetic and phenotypic map of 5p to be defined, even if results from the studies reported up to now are not completely in agreement. Genotype-phenotype correlation studies showed a clinical and cytogenetic variability. The identification of phenotypic subsets associated with a specific size and type of deletion is of diagnostic and prognostic relevance. Specific growth and psychomotor development charts have been established. Two genes, Semaphorin F (SEMAF) and delta-catenin (CTNND2), which have been mapped to the "critical regions", are potentially involved in cerebral development and their deletion may be associated with mental retardation in CdCS patients. Deletion of the telomerase reverse transcriptase (hTERT) gene, localised to 5p15.33, could contribute to the phenotypic changes in CdCS. The critical regions were recently refined by using array comparative genomic hybridisation. The cat-like cry critical region was further narrowed using quantitative polymerase chain reaction (PCR) and three candidate genes were characterised in this region. The diagnosis is based on typical clinical manifestations. Karyotype analysis and, in doubtful cases, FISH analysis will confirm the diagnosis. There is no specific therapy for CdCS but early rehabilitative and educational interventions improve the prognosis and considerable progress has been made in the social adjustment of CdCS patients.
Collapse
|
7
|
Zhang A, Zheng C, Hou M, Lindvall C, Li KJ, Erlandsson F, Björkholm M, Gruber A, Blennow E, Xu D. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. Am J Hum Genet 2003; 72:940-8. [PMID: 12629597 PMCID: PMC1180356 DOI: 10.1086/374565] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2002] [Accepted: 01/13/2003] [Indexed: 01/11/2023] Open
Abstract
Cri du chat syndrome (CdCS) results from loss of the distal portion of chromosome 5p, where the telomerase reverse transcriptase (hTERT) gene is localized (5p15.33). hTERT is the rate-limiting component for telomerase activity that is essential for telomere-length maintenance and sustained cell proliferation. Here, we show that a concomitant deletion of the hTERT allele occurs in all 10 patients with CdCS whom we examined. Induction of hTERT mRNA in proliferating lymphocytes derived from five of seven patients was lower than that in unaffected control individuals (P<.05). The patient lymphocytes exhibited shorter telomeres than age-matched unaffected individuals (P<.0001). A reduction in replicative life span and a high rate of chromosome fusions were observed in cultured patient fibroblasts. Reconstitution of telomerase activity by ectopic expression of hTERT extended the telomere length, increased the population doublings, and prevented the end-to-end fusion of chromosomes. We conclude that hTERT is limiting and haploinsufficient for telomere maintenance in humans in vivo. Accordingly, the hTERT deletion may be one genetic element contributing to the phenotypic changes in CdCS.
Collapse
Affiliation(s)
- Anju Zhang
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Chengyun Zheng
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Mi Hou
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Charlotta Lindvall
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Ke-Jun Li
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Fredrik Erlandsson
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Magnus Björkholm
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Astrid Gruber
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Elisabeth Blennow
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| | - Dawei Xu
- Department of Pathology and Oncology, Department of Medicine, Division of Hematology, Department of Molecular Medicine, and Department of Biosciences at Novum, Karolinska Institutet and Hospital, Stockholm; and Shaanxi Provincial Hospital, Xian, China
| |
Collapse
|